<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rates of neurodevelopmental outcomes among survivors in selected studies for infants 22 to 25 weeks gestation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rates of neurodevelopmental outcomes among survivors in selected studies for infants 22 to 25 weeks gestation</h1>
<div class="graphic"><div class="figure"><div class="ttl">Rates of neurodevelopmental outcomes among survivors in selected studies for infants 22 to 25 weeks gestation</div><div class="cntnt"><table cellspacing="0"><colgroup span="8" width="8%"></colgroup><colgroup width="36%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1" rowspan="2">Study</td> <td class="subtitle1" rowspan="2">Study year</td> <td class="subtitle1" rowspan="2">Outcome</td> <td class="subtitle1" colspan="5">Rate (%) by gestational week</td> <td class="subtitle1" rowspan="2">Comment</td> </tr> <tr class="divider_bottom"> <td class="subtitle2">22</td> <td class="subtitle2">23</td> <td class="subtitle2">24</td> <td class="subtitle2">25</td> <td class="subtitle2">Total</td> </tr> <tr> <td rowspan="3">Bell<sup>[1]</sup></td> <td rowspan="3">2013 to 2016</td> <td>Moderate to severe CP</td> <td class="centered">23</td> <td class="centered">18</td> <td class="centered">11</td> <td class="centered">6</td> <td class="centered">10</td> <td>Defined as GMFCS level 2 or greater</td> </tr> <tr> <td>Cognitive impairment</td> <td class="centered">26</td> <td class="centered">23</td> <td class="centered">21</td> <td class="centered">12</td> <td class="centered">17</td> <td>Defined as Bayley-III composite cognitive score &lt;70</td> </tr> <tr> <td>Motor impairment</td> <td class="centered">23</td> <td class="centered">28</td> <td class="centered">22</td> <td class="centered">12</td> <td class="centered">18</td> <td>Defined as Bayley-III composite motor score &lt;70</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="3"><span class="nowrap_whitespace">Younge<sup>[2]</sup></span></td> <td>2000 to 2003</td> <td>Impairment</td> <td class="centered">67</td> <td class="centered">65</td> <td class="centered">44</td> <td class="centered">N/A</td> <td class="centered">N/A</td> <td rowspan="3">Neurodevelopmental impairment assessed at 18 to 24 months and defined as: Moderate or severe CP, moderate to severe gross motor impairment, deafness, blindness, or cognitive impairment based on Bayley-II (2000 to 2005) or Bayley-III (2006 to 2011) scores</td> </tr> <tr class="highlight_lght_gray_text"> <td>2004 to 2007</td> <td>Impairment</td> <td class="centered">69</td> <td class="centered">43</td> <td class="centered">45</td> <td class="centered">N/A</td> <td class="centered">N/A</td> </tr> <tr class="highlight_lght_gray_text"> <td>2008 to 2011</td> <td>Impairment</td> <td class="centered">63</td> <td class="centered">46</td> <td class="centered">42</td> <td class="centered">N/A</td> <td class="centered">N/A</td> </tr> <tr> <td rowspan="6"><span class="nowrap_whitespace">Carlo<sup>[3]</sup></span></td> <td rowspan="6">1993 to 2009</td> <td colspan="6">Impairment</td> <td rowspan="3">MDI or PDI ≤70, moderate or severe CP, blindness, or bilateral hearing loss requiring amplification at 18 to 22 months corrected age</td> </tr> <tr> <td class="indent1">ANS</td> <td class="centered">59</td> <td class="centered">55</td> <td class="centered">42</td> <td class="centered">34</td> <td class="centered">39</td> </tr> <tr> <td class="indent1">No ANS</td> <td class="centered">56</td> <td class="centered">56</td> <td class="centered">52</td> <td class="centered">44</td> <td class="centered">49</td> </tr> <tr> <td colspan="6">CP</td> <td rowspan="3">Moderate or severe CP</td> </tr> <tr> <td class="indent1">ANS</td> <td class="centered">14</td> <td class="centered">11</td> <td class="centered">10</td> <td class="centered">7</td> <td class="centered">9</td> </tr> <tr> <td class="indent1">No ANS</td> <td class="centered">16</td> <td class="centered">19</td> <td class="centered">12</td> <td class="centered">9</td> <td class="centered">12</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="3"><span class="nowrap_whitespace">Serenius<sup>[4]</sup></span></td> <td rowspan="3">2004 to 2007</td> <td>Mild</td> <td class="centered">40</td> <td class="centered">19</td> <td class="centered">33</td> <td class="centered">29</td> <td class="centered">29</td> <td>Mild disability: scores on any Bayley-III scales between 1 and 2 SD below the mean or mild CP at 2.5 years corrected age</td> </tr> <tr class="highlight_lght_gray_text"> <td>Moderate</td> <td class="centered">20</td> <td class="centered">30</td> <td class="centered">21</td> <td class="centered">17</td> <td class="centered">20</td> <td>Moderate disability: scores on any Bayley-III scales between 2 and 3 SD below the mean, moderate CP, or moderate visual or hearing impairment at 2.5 years corrected age</td> </tr> <tr class="highlight_lght_gray_text"> <td>Severe</td> <td class="centered">40</td> <td class="centered">21</td> <td class="centered">13</td> <td class="centered">10</td> <td class="centered">13</td> <td>Severe disability: score &gt;3 SD below the mean for any of the Bayley-III scales, severe CP, or bilateral blindness or deafness at 2.5 years corrected age</td> </tr> <tr> <td rowspan="2"><span class="nowrap_whitespace">EPICure2<sup>[5]</sup></span></td> <td rowspan="2">2006</td> <td>Severe Impairment</td> <td class="centered">10</td> <td class="centered">29</td> <td class="centered">19</td> <td class="centered">16</td> <td class="centered">10</td> <td rowspan="2">Neurodevelopmental impairment assessed between 27 and 48 months of age. Severe impairment defined as blindness, non-ambulant CP, deafness, and a developmental quotient (DQ) &lt;3 SD below the mean. Moderate impairment defined as ambulant CP, functionally impaired vision, hearing loss improved by hearing aids, and DQ between 2 and 3 SD.</td> </tr> <tr> <td>Moderate impairment</td> <td class="centered">42</td> <td class="centered">18</td> <td class="centered">16</td> <td class="centered">12</td> <td class="centered">10</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="2"><span class="nowrap_whitespace">Ishii<sup>[6]</sup></span></td> <td rowspan="2">2003 to 2005</td> <td>Impairment</td> <td class="centered">52</td> <td class="centered">57</td> <td class="centered">37</td> <td class="centered">37</td> <td class="centered">42</td> <td>Moderate to severe CP, hearing impairment requiring amplification, blindness in one or both eyes, or a score of &lt;70 at 36 to 42 months corrected age on the Kyoto Scale of Psychological Development (KSPD)</td> </tr> <tr class="highlight_lght_gray_text"> <td>Profound impairment</td> <td class="centered">30</td> <td class="centered">40</td> <td class="centered">16</td> <td class="centered">17</td> <td class="centered">23</td> <td>Severe CP or a score &lt;50 at 36 to 42 months corrected age on KSPD</td> </tr> <tr> <td rowspan="2"><span class="nowrap_whitespace">Tyson<sup>[7]</sup></span></td> <td rowspan="2">1998 to 2003</td> <td>Impairment</td> <td class="centered">80</td> <td class="centered">65</td> <td class="centered">50</td> <td class="centered">36</td> <td class="centered">47</td> <td>MDI or PDI &lt;70, moderate or severe CP, blindness, or bilateral hearing loss requiring amplification at 18 to 22 months corrected age</td> </tr> <tr> <td>Profound impairment</td> <td class="centered">60</td> <td class="centered">38</td> <td class="centered">23</td> <td class="centered">17</td> <td class="centered">24</td> <td>MDI or PDI &lt;50 or severe gross motor deficit requiring adult assistance to move at 18 to 22 months corrected age</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="2"><span class="nowrap_whitespace">Epipage<sup>[8]</sup></span></td> <td rowspan="2">1997</td> <td>CP</td> <td class="centered">N/A</td> <td class="centered">33</td> <td class="centered">13</td> <td class="centered">16.3</td> <td class="centered">16</td> <td>As defined by European Surveillance of CP Network at two years</td> </tr> <tr class="highlight_lght_gray_text"> <td>Cognitive score &lt;70</td> <td class="centered">N/A</td> <td class="centered">0</td> <td class="centered">23</td> <td class="centered">12</td> <td class="centered">14</td> <td>K-ABC test at five to six years in 57% of children without severe disability</td> </tr> <tr> <td rowspan="2"><span class="nowrap_whitespace">EPICure1<sup>[9]</sup></span></td> <td rowspan="2">1995</td> <td>CP</td> <td class="centered">N/A</td> <td class="centered">13</td> <td class="centered">21</td> <td class="centered">20</td> <td class="centered">20</td> <td>As defined by European Surveillance of CP Network at two years</td> </tr> <tr> <td>Cognitive score &lt;70</td> <td class="centered">N/A</td> <td class="centered">11</td> <td class="centered">14</td> <td class="centered">7</td> <td class="centered">10</td> <td>K-ABC test at five to six years in 64% of children without severe disability</td> </tr> </tbody></table></div><div class="graphic_footnotes">CP: cerebral palsy; N/A: not available; K-ABC test: Mental Processing Composite of the Kaufman Assessment Battery for Children; MDI: Mental Developmental Index of the Bayley Scales of Infant Development-II; PDI: Psychomotor Developmental Index of the Bayley Scales of Infant Development-II; ANS: antenatal steroid therapy; SD: standard deviation; GMFCS: gross motor function classification system.</div><div class="graphic_reference">References:
<ol>
<li>Bell EF, Hintz SR, Hansen NI, et al. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA 2022; 327:248.</li>
<li>Younge N, Goldstein RF, Bann CM, et al. Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 2017; 376:617.</li>
<li>Carlo WA, McDonald SA, Fanaroff AA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA 2011; 306:2348.</li>
<li>Serenius F, Källén K, Blennow M, et al. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA 2013; 309:1810.</li>
<li>Moore T, Hennessy EM, Myles J, et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012; 345:e7961.</li>
<li>Ishii N, Kono Y, Yonemoto N, et al. Outcomes of infants born at 22 and 23 weeks' gestation. Pediatrics 2013; 132:62.</li>
<li>Tyson JE, Parikh NA, Langer J, et al. Intensive care for extreme prematurity--moving beyond gestational age. N Engl J Med 2008; 358:1672.</li>
<li>Larroque B, Bréart G, Kaminski M, et al. Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child Fetal Neonatal Ed 2004; 89:F139.</li>
<li>Costeloe K, Hennessy E, Gibson AT, et al. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000; 106:659.</li>
</ol></div><div id="graphicVersion">Graphic 63848 Version 16.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
